Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.45% |
| 2 | Technology | 16.09% |
| 3 | Consumer Staples | 10.57% |
| 4 | Consumer Discretionary | 9.95% |
| 5 | Communication Services | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3126
Amtech Systems
ASYS
$280M
| $226K | ﹤0.01% |
46,362
+23,596
| +104% | +$117K |
|
|
FURY
3127
Fury Gold Mines
FURY
$116M
| $226K | ﹤0.01% |
+56,185
| New | +$150K |
|
3128
MainStreet Bancshares
MNSB
$179M
| $226K | ﹤0.01% |
+17,141
| New | +$238K |
|
|
BORR
3129
Borr Drilling
BORR
$1.25B
| $225K | ﹤0.01% |
+100,550
| New | +$189K |
|
|
BPTH
3130
DELISTED
Bio-Path Holdings Inc
BPTH
| $225K | ﹤0.01% |
2,225
-817
| -27% | -$84.7K |
|
|
KZIA
3131
Kazia Therapeutics
KZIA
$151M
| $224K | ﹤0.01% |
1,321
+636
| +93% | +$92.9K |
|
3132
Heritage Financial
HFWA
$1.23B
| $222K | ﹤0.01% |
11,100
-15,000
| -57% | -$283K |
|
3133
TORM
TRMD
$3.01B
| $220K | ﹤0.01% |
32,131
-178,680
| -85% | -$1.42M |
|
|
SLAI
3134
DELISTED
SOLAI Ltd ADS
SLAI
| $219K | ﹤0.01% |
+813
| New | +$221K |
|
3135
i3 Verticals
IIIV
$325M
| $218K | ﹤0.01% |
7,200
-67,200
| -90% | -$1.71M |
|
3136
First Trust Emerging Markets AlphaDEX Fund
FEM
$788M
| $216K | ﹤0.01% |
+10,300
| New | +$204K |
|
|
PINE
3137
Alpine Income Property Trust
PINE
$347M
| $216K | ﹤0.01% |
+13,300
| New | +$172K |
|
3138
VEON
VEON
$3.93B
| $214K | ﹤0.01% |
+4,764
| New | +$192K |
|
|
SWKH
3139
DELISTED
SWK Holdings
SWKH
| $213K | ﹤0.01% |
+22,464
| New | +$223K |
|
3140
Vanguard Extended Market ETF
VXF
$32.3B
| $213K | ﹤0.01% |
1,800
-1,400
| -44% | -$150K |
|
|
SACH
3141
Sachem Capital Corp
SACH
$37.6M
| $212K | ﹤0.01% |
71,545
-165,250
| -70% | -$423K |
|
3142
The ONE Group
STKS
$56.8M
| $212K | ﹤0.01% |
130,254
-456
| -0.3% | -$741 |
|
|
NYMX
3143
DELISTED
Nymox Pharmaceutical Corp
NYMX
| $211K | ﹤0.01% |
59,375
-45,325
| -43% | -$143K |
|
3144
Kinetik
KNTK
$4.16B
| $210K | ﹤0.01% |
+33,200
| New | +$227K |
|
|
XYF
3145
X Financial
XYF
$214M
| $210K | ﹤0.01% |
77,627
+24,866
| +47% | +$67.3K |
|
|
FWP
3146
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
| $210K | ﹤0.01% |
+34,097
| New | +$217K |
|
3147
iShares Global Clean Energy ETF
ICLN
$2.11B
| $209K | ﹤0.01% |
16,700
-19,100
| -53% | -$215K |
|
|
PENG
3148
Penguin Solutions Inc
PENG
$3.12B
| $209K | ﹤0.01% |
+15,400
| New | +$196K |
|
3149
Matinas BioPharma
MTNB
$1.49M
| $206K | ﹤0.01% |
5,340
-15,146
| -74% | -$581K |
|
|
LEVL
3150
DELISTED
Level One Bancorp, Inc. Common Stock
LEVL
| $206K | ﹤0.01% |
12,300
-8,281
| -40% | -$144K |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 25% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.